Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

View All Documentation

V900760

Sigma-Aldrich

Sodium stearate

Vetec™, reagent grade

Synonym(s):

Octadecanoic acid sodium salt, Stearic acid sodium salt

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
CH3(CH2)16COONa
CAS Number:
822-16-2
Molecular Weight:
306.46
Beilstein/REAXYS Number:
3576813
EC Number:
212-490-5
MDL number:
MFCD00036404
UNSPSC Code:
12352211
PubChem Substance ID:
329830131
Pricing and availability is not currently available.

grade

reagent grade

product line

Vetec™

form

solid

functional group

ester

shipped in

ambient

storage temp.

room temp

SMILES string

[Na+].CCCCCCCCCCCCCCCCCC([O-])=O

InChI

1S/C18H36O2.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;/h2-17H2,1H3,(H,19,20);/q;+1/p-1

InChI key

RYYKJJJTJZKILX-UHFFFAOYSA-M

Looking for similar products? Visit Product Comparison Guide

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

Storage Class

13 - Non Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
WXBB0979

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Robert Damitz et al.
International journal of pharmaceutics, 486(1-2), 232-241 (2015-04-04)
Intravenous injections of propofol emulsions are accompanied by pain likely due to the interaction of the dissolved drug with endothelial cells of the vasculature. It is commonly hypothesized that reducing the aqueous phase concentration of propofol could reduce pain. To
T Aikawa et al.
Biomaterials science, 3(6), 861-869 (2015-07-30)
In order for patients to avail of the therapeutic benefits of antioxidant drugs efficiently and conveniently, a robust oral delivery system needs to be developed. However, a common problem in oral drug delivery is ensuring that the drug remains functionally
Luigi Battaglia et al.
Journal of pharmaceutical sciences, 103(7), 2157-2165 (2014-05-16)
The major obstacle to glioblastoma pharmacological therapy is the overcoming of the blood-brain barrier (BBB). In literature, several strategies have been proposed to overcome the BBB: in this experimental work, solid lipid nanoparticles (SLN), prepared according to fatty acid coacervation

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service